Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.13p
   
  • Change Today:
    -0.18p
  • 52 Week High: 6.25
  • 52 Week Low: 0.88
  • Currency: UK Pounds
  • Shares Issued: 4,766.44m
  • Volume: 576,496
  • Market Cap: £148.95m
  • RiskGrade: 268

Latest ShareCast News

Allergy Therapeutics starts dosing peanut allergy vaccine candidate

By Josh White

Date: Monday 27 Mar 2023

(Sharecast News) - Allergy Therapeutics, a UK-based biotechnology company specialising in allergy vaccines, announced the start of the first application of its 'VLP Peanut' vaccine candidate in peanut-allergic patients on Monday.

Allergy Therapeutics confident in funding as results remain late

By Josh White

Date: Friday 20 Jan 2023

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics said in an update on Friday that it expects first-half revenue of £39.9m, making for a decrease of 18% year-on-year.

Allergy Therapeutics pauses production at Freeman facility

By Josh White

Date: Tuesday 04 Oct 2022

(Sharecast News) - Biotechnology company Allergy Therapeutics has "proactively paused" production at the Freeman facility, part of its Worthing manufacturing site, to accelerate ongoing site improvements, it announced on Tuesday.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 3.13p
Change Today -0.18p
% Change -5.30 %
52 Week High 6.25
52 Week Low 0.88
Volume 576,496
Shares Issued 4,766.44m
Market Cap £148.95m
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.26% below the market average19.26% below the market average19.26% below the market average19.26% below the market average19.26% below the market average
9.80% above the sector average9.80% above the sector average9.80% above the sector average9.80% above the sector average9.80% above the sector average
Price Trend
29.83% below the market average29.83% below the market average29.83% below the market average29.83% below the market average29.83% below the market average
1.82% above the sector average1.82% above the sector average1.82% above the sector average1.82% above the sector average1.82% above the sector average
Income Not Available
Growth
84.18% below the market average84.18% below the market average84.18% below the market average84.18% below the market average84.18% below the market average
82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average

AGY Dividends

No dividends found

Trades for 09-May-2024

Time Volume / Share Price
15:58 54,239 @ 3.05p
15:26 12,500 @ 3.05p
14:03 343 @ 3.24p
14:00 2,500 @ 3.38p
14:00 2,500 @ 3.38p

AGY Key Personnel

CEO Manuel Llobet

Top of Page